Therapeutic Breakfast Series Preparing for Coverage & Reimbursement: Demonstrating Value
The U.S. payer landscape is an ever-changing, complex mix of public and private payers and plan sponsors / administrators. Payer policies are becoming increasingly focused on a product’s value proposition, its value arguments, and its comparison against products in the same or similar therapeutic categories. Payers are becoming more selective in determining preferred products and more apt to apply coverage criteria / restrictions to non-preferred products. The cost shift trend to increase patient out-of-pocket co-pay / coinsurance continues, especially with specialty products. To ensure product access at launch, it is important for companies to identify and develop the payer value proposition and supporting arguments concurrent with the clinical program development. Join our panel to learn about the critical elements and timing for development of a successful coverage & reimbursement strategy, the current and emerging payer trends that will impact products in your development portfolio, and jump start the roadmap for your commercial launch.
Former Vice President of Health Systems, ALZA
Adina L. Safer, MBA, MPH
Vice President, Business Development, TheraCom
Former Vice President of Marketing,
Former Vice President of Health Systems,
Executive Director, Health Systems,
Peter K Yi
Director, Commercial Operations
ChemGenex Pharmaceuticals Inc.
|What:||Therapeutic Breakfast Series
Preparing for Coverage & Reimbursement: Demonstrating Value
|When:||April 22, 2010
8:00 – 10:00am
|Where:||Wells Fargo Insurance Services Inc.
305 Walnut Street.
Redwood City, CA 94063
|Attire:||Business attire suggested|
|Cost:||Early registrations through April 20th:
$10.00 – BayBio Members
$20.00 – Non-Members
On-Site Registration, April 22nd: